Trader’s Recap: Check-Cap Ltd. (NASDAQ:CHEK), ON Semiconductor Corp. (NASDAQ:ON), Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), CHS, Inc. (NASDAQ:CHSCP), Agree Realty Corp. (NYSE:ADC)

Check-Cap Ltd. (NASDAQ:CHEK) belongs to Healthcare sector. Its weekly performance is 1.31%. On last trading day company shares ended up $3.86. Check-Cap Ltd. (NASDAQ:CHEK) distance from 50-day simple moving average (SMA50) is -4.23%. On July 6, Check-Cap Ltd. (NASDAQ:CHEK), announced that it will hold an Extraordinary General Meeting of Shareholders on August 13, 2015 (the “Meeting”) for the following purposes: To approve the adoption of the Check-Cap Ltd. Compensation Policy for Executive Officers and Directors; To approve the adoption of the Check-Cap Ltd. 2015 Equity Incentive Plan and the Check-Cap Ltd. 2015 United States Sub-Plan to the 2015 Equity Incentive Plan for U.S. tax purposes; and To approve the terms of engagement of Mr. William Densel, as Chief Executive Officer.

ON Semiconductor Corp. (NASDAQ:ON) shares advanced 4.04% in last trading session and ended the day at $11.34. ON Gross Margin is 34.10% and its return on assets is 5.00%. ON Semiconductor Corp. (NASDAQ:ON) quarterly performance is -2.07%. On July 09, ON Semiconductor (NASDAQ:ON), driving energy efficiency innovations, is expanding its highly-regarded 1/3-inch 1 megapixel (MP) image sensor portfolio with early sampling of the company’s first backside illuminated (BSI) sensor technology for the automotive imaging market. The innovative new sensor technology delivers 4x better low light signal-to-noise ratio, a 40 percent increase in visible light sensitivity, and greater than 60 percent improvement in near infrared (NIR) performance than the current market leading AR0132AT CMOS image sensor for advanced driver assistance systems (ADAS).

On 10 July, Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) shares advanced 4.27% and was closed at $4.88. CPRX EPS growth in last 5 year was 12.90%. Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) year to date (YTD) performance is 64.31%. On June 30, Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) announced the appointment of Gary Ingenito, M.D., Ph.D, as Chief Medical Officer. Dr. Ingenito has more than 25 years of experience leading pharmaceutical development for drugs and biologics. In this new role, he will oversee all clinical development programs, medical affairs, regulatory and other related functions. Dr. Ingenito will report to Dr. Steven Miller, Catalyst’s Chief Operating Officer and Chief Scientific Officer. Following Dr. Ingenito’s joining Catalyst, the current Chief Medical Officer, Charles Gorodetzky, M.D., Ph.D, will continue to serve as a consultant to the company.

CHS, Inc. (NASDAQ:CHSCP) belongs to Consumer Goods sector. Its net profit margin is 2.60% and weekly performance is -0.79%. On last trading day company shares ended up $30.25. CHS, Inc. (NASDAQ:CHSCP) distance from 50-day simple moving average (SMA50) is -1.27%. CHS, Inc. (NASDAQ:CHSCP) reported that its net income attributable to the company for the third quarter of fiscal 2015 were $178.1 million, down 53 percent from $379.5 million for the same period of fiscal 2014.
The third quarter of fiscal 2014 included a one-time gain of $108.8 million attributed to the establishment of the Ardent Mills flour milling joint venture in May 2014.

Agree Realty Corp. (NYSE:ADC) shares moved up 1.19% in last trading session and ended the day at $30.51. ADC Gross Margin is 91.00% and its return on assets is 4.40%. Agree Realty Corp. (NYSE:ADC) quarterly performance is -5.06%. Agree Realty Corp. (NYSE:ADC) announced that Mr. Brian Dickman has resigned as Chief Financial Officer and Secretary to pursue another business opportunity. The resignation will take effect after a transition period which is expected to end on or around August 4, 2015. Mr. Kenneth Howe, former Chief Financial Officer of the Company, has been appointed to serve as interim Chief Financial Officer upon Mr. Dickman’s departure. Mr. Howe has been with the Company since its initial public offering in 1994, serving as Chief Financial Officer from April 1994 to November 2010, and is currently the Company’s Director of Tax.

Leave a Reply

Your email address will not be published. Required fields are marked *